New York, NY -- (SBWIRE) -- 12/03/2013 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Merrimack Pharmaceuticals Inc(NASDAQ:MACK), ParkerVision, Inc.(NASDAQ:PRKR), E-House (China) Holdings Limited (ADR)(NYSE:EJ) , Keryx Biopharmaceuticals (NASDAQ:KERX)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Merrimack Pharmaceuticals Inc(NASDAQ:MACK), during the previous trading session, showed a positive movement of +6.60%.Year to date performance of the stock remained negative with the decline of -31.03%. The stock traded with volume of 3.69 million shares, while its average trading volume remained2.12million shares. Its closing price was $4.20 while it started its day-trade at $4.04. Its 52-week price range was $2.05 - $7.50.
For How Long MACK will Fight for Profitability? Read This Trend Analysis report
ParkerVision, Inc.(NASDAQ:PRKR) remained among the day gainers and traded with volume of 1.28 million shares in the last session, as compared to average volume of 3.52 million shares.Previous 5 days graph demonstrated an optimistic move of +12.66 %. Its quarterly performance remained in the green with the percentage of +34.44, while its year to date performance showed that the stock advanced overall +119.21%.
For How Long PRKR’s Gloss will Attract Investors? Find out via this report
E-House (China) Holdings Limited (ADR)(NYSE:EJ) started its trading session with the price of $10.72 and closed at $11.35 by scoring +6.27%. It traded with total volume of 5.60 million shares, while the average trading volume remained 2.83 million shares. The 52 week range of the stock remained $2.95- $12.61, while its day lowest price was $10.65 and it hit its day highest price at $11.41. The company’s total market capitalization is $1.53 billion along with 134.95 million shares outstanding.
Will EJ Continue To Move Higher? Find Out Here
Keryx Biopharmaceuticals (NASDAQ:KERX) stock made opening at $13.99 and, as day trade closed, its price was $14.59 after scoring +5.04% . Total traded volume of the stock was 4.11million shares, while company’s average volume remained 3.08million shares. The intraday price range was $13.91- $14.87, while its 52 week range was $2.50- $14.87.
Why Should Investors Buy KERX After The Recent Gain? Just Go Here and Find Out
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)